Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
04/2004
04/29/2004US20040082577 Amino methyl imidazoles as C5a receptor modulators
04/29/2004US20040082572 Benzodiazepine derivatives as app modulators
04/29/2004US20040082571 Substituted piperazines
04/29/2004US20040082568 Tetrazolylpropionamides as inhibitors of Abeta protein production
04/29/2004US20040082566 Pyrrolidine sulfonamides
04/29/2004US20040082561 Antilipemic agents; anticholesterol agents
04/29/2004US20040082559 Vitronectin receptor antagonists
04/29/2004US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors
04/29/2004US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin
04/29/2004US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease
04/29/2004US20040082475 Herbicides
04/29/2004CA2501547A1 Substituted indoles and their use as hcv inhibitors
04/29/2004CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands
04/29/2004CA2501418A1 Novel compounds
04/29/2004CA2500320A1 Novel compounds with antibacterial activity
04/28/2004EP1413579A1 Imidazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing them
04/28/2004EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
04/28/2004EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres
04/28/2004EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
04/28/2004EP1412327A2 Inhibitors of protein kinase for the treatment of disease
04/28/2004EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines
04/28/2004EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists
04/28/2004EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors
04/28/2004EP1411942A1 Substituted anilinic piperidines as mch selective antagonists
04/28/2004EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors
04/28/2004EP1411928A1 Viral polymerase inhibitors
04/28/2004EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS
04/28/2004CN1492864A Pyrazolyl pyrimidines
04/28/2004CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor
04/28/2004CN1491949A Pyridazine-3-one derivatives, their use, and intermediate preparing them
04/28/2004CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative
04/28/2004CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
04/28/2004CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors
04/27/2004US6727364 Antiinflammatory agents
04/27/2004US6727273 Therapy for osteoporosis, anticancer agents
04/27/2004US6727266 Substituted tryptophan derivatives
04/27/2004US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents
04/27/2004US6727255 Brain, nervous system and psychological disorders
04/27/2004US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
04/27/2004US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's
04/27/2004US6727206 Substituted aryl ketones
04/27/2004US6727053 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent
04/27/2004US6727041 Optical recording media
04/27/2004CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds
04/23/2004CA2445817A1 Novel derivatives of imidazoline, process for their preparation and pharmaceutical compositions containing them
04/22/2004WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives
04/22/2004WO2004033435A1 Quinazolinone derivatives useful as anti-hyperalgesic agents
04/22/2004WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders
04/22/2004WO2004033432A1 Novel pyrazole compounds having antifungal activity
04/22/2004WO2004033431A2 Hydroxypyrazoles for use against metabolic-related disorders
04/22/2004WO2004033422A2 Modulation of anxiety through blockade of anandamide hydrolysis
04/22/2004WO2004032871A2 Piperazine and piperazinone inhibitors of factor xa
04/22/2004WO2004032861A2 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
04/22/2004WO2004032846A2 Triazolone and triazolethione derivatives
04/22/2004WO2004032834A2 Thrombin inhibitors
04/22/2004WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same
04/22/2004WO2004016597A3 Protein kinase inhibitors and uses thereof
04/22/2004WO2004014300A3 Tyrosine kinase inhibitors
04/22/2004WO2004002986A3 Novel benzimidazole derivatives
04/22/2004WO2003072541A3 Chemical compounds
04/22/2004WO2003057214A8 Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands
04/22/2004WO2002074767A8 Metalloproteinase inhibitors
04/22/2004WO2002074752A8 Metalloproteinase inhibitors
04/22/2004WO2002074748A8 Metalloproteinase inhibitors
04/22/2004US20040077877 Jun n-terminal kinase inhibitors
04/22/2004US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector
04/22/2004US20040077852 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers
04/22/2004US20040077851 Receptor selective cannabimimetic aminoalkylindoles
04/22/2004US20040077705 Cyclopentyl indole derivatives
04/22/2004US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease
04/22/2004US20040077693 Integrin receptor inhibitors
04/22/2004US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors
04/22/2004US20040077671 Sorbitol dehydrogenase inhibitors
04/22/2004US20040077670 Novel sulfamides and their use as endothelin receptor antagonists
04/22/2004US20040077668 Compounds, compositins, and methods
04/22/2004US20040077667 Quinazolinone derivatives
04/22/2004US20040077662 Compounds, methods and compositions
04/22/2004US20040077657 HT3 Receptor antagonists; amyotrophic lateral sclerosis, premenstrual tension, obsessive-compulsive disorder; Parkinson*s, Alzheimer*s, and Huntington*s disease; memory, eating, psychological, and nervous system disorders
04/22/2004US20040077653 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders
04/22/2004US20040077650 Cannabinoid receptor ligands and uses thereof
04/22/2004US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis
04/22/2004US20040077619 Calcium receptor modulating agents
04/22/2004US20040077019 Tagging compounds and process for use in aida libraries
04/22/2004US20040076673 Oral pharmaceutical composition containing a block copolymer
04/22/2004DE10296560T5 Benzotriazole und deren Verwendung als UV-Lichtstabilisatoren Benzotriazoles and their use as UV-light stabilizers
04/22/2004DE10247680A1 New benzotriazole-1-carboxylic acid amide or ester compounds, are hormone-sensitive lipase inhibitors useful for treating non-insulin dependent diabetes or diabetic syndrome
04/22/2004DE10153346A1 Substituierte Indole Substituted indoles
04/22/2004CA2501529A1 Quinazolinone derivatives useful as anti-hyperalgesic agents
04/22/2004CA2501506A1 Modulation of anxiety through blockade of anandamide hydrolysis
04/22/2004CA2501352A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives
04/21/2004EP1411049A1 Estrogen Agonists/Antagonists
04/21/2004EP1411047A1 Intercalators having affinity for DNA and methods of use
04/21/2004EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay
04/21/2004EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors
04/21/2004EP1409480A1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
04/21/2004EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
04/21/2004EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression
04/21/2004EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists
04/21/2004EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
04/21/2004EP1409024A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules